Health and Science

New Jersey jury clears J&J of liability in latest talc cancer trial

Key Points
  • A New Jersey jury on Wednesday cleared Johnson & Johnson of liability in a lawsuit by a man who alleged asbestos in the company's talc-based products, including baby powder, caused his mesothelioma.
  • J&J, which faces some 13,000 talc-related lawsuits nationwide, denies that its talc causes cancer, saying numerous studies and tests by regulators worldwide have shown its talc to be safe and asbestos-free.
  • J&J in a statement said the jury's decision underscored decades of clinical evidence and scientific studies by medical experts around the world supporting the safety of Johnsons Baby Powder.
Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York.
Lucas Jackson | Reuters

A New Jersey jury on Wednesday cleared Johnson & Johnson of liability in a lawsuit by a man who alleged asbestos in the company's talc-based products, including baby powder, caused his mesothelioma.

The unanimous jury returned its verdict in Middlesex County Superior Court in New Brunswick, just miles from J&J's headquarters, in the case of plaintiff Ricardo Rimondi.

J&J, which faces some 13,000 talc-related lawsuits nationwide, denies that its talc causes cancer, saying numerous studies and tests by regulators worldwide have shown its talc to be safe and asbestos-free.

In a trial that lasted a month, lawyers for Rimondi told jurors that asbestos-tainted J&J talc products caused the man's mesothelioma, a type of cancer that has been linked to asbestos exposure. But the jury on Wednesday returned its verdict in favor of the company after only half an hour of deliberations, according to a livestream of the proceedings by Courtroom View Network.

J&J in a statement said the jury's decision underscored decades of clinical evidence and scientific studies by medical experts around the world supporting the safety of Johnsons Baby Powder.

Next Article
Key Points
  • Walgreens will sell CBD creams, patches and sprays in nearly 1,500 stores in select states. 
  • Walgreens will sell the cannabis-based products in Oregon, Colorado, New Mexico, Kentucky, Tennessee, Vermont, South Carolina, Illinois and Indiana. 
  • Rival drugstore chain CVS introduced CBD-containing topicals, including creams and salves, to stores in eight states earlier in March.